Literature DB >> 21085943

Clinical spectrum in a family with tropomyosin-mediated hypertrophic cardiomyopathy and sudden death in childhood.

Majd Makhoul1, Michael J Ackerman, Dianne L Atkins, Ian H Law.   

Abstract

This report demonstrates variable clinical courses in several members of a family with tropomyosin-mediated hypertrophic cardiomyopathy (HCM) (L185R mutation). The index case was an 8-year-old girl who died from sudden cardiac death and was diagnosed with HCM on autopsy. Her father had minimal hypertrophy but had an implantable cardioverter defibrillator placed prophylactically with no appropriate shocks. Two brothers progressed from normal phenotype to HCM on follow-up, the younger with significant hypertrophy and the older with mild hypertrophy. They both had malignant arrhythmia courses with VF, which was terminated by ICD shock. In conclusion, family members with same genotype can have significantly variable phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085943     DOI: 10.1007/s00246-010-9843-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

Review 1.  Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

Authors:  William J McKenna; Elijah R Behr
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

2.  A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.

Authors:  Sara L Van Driest; Melissa L Will; Dianne L Atkins; Michael J Ackerman
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

Review 3.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

Review 4.  Hypertrophic cardiomyopathy.

Authors:  Liviu C Poliac; Michael E Barron; Barry J Maron
Journal:  Anesthesiology       Date:  2006-01       Impact factor: 7.892

Review 5.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

6.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Authors:  F Cecchi; I Olivotto; A Montereggi; G Santoro; A Dolara; B J Maron
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

8.  Significance of left atrial volume in patients < 20 years of age with hypertrophic cardiomyopathy.

Authors:  Shaji C Menon; Michael J Ackerman; Frank Cetta; Patrick W O'Leary; Benjamin W Eidem
Journal:  Am J Cardiol       Date:  2008-09-11       Impact factor: 2.778

9.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.

Authors:  Michael J Ackerman; Sara L VanDriest; Steve R Ommen; Melissa L Will; Rick A Nishimura; A Jamil Tajik; Bernard J Gersh
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

10.  Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.

Authors:  Jamie A Decker; Joseph W Rossano; E O'Brian Smith; Bryan Cannon; Sarah K Clunie; Corey Gates; John L Jefferies; Jeffrey J Kim; Jack F Price; William J Dreyer; Jeffrey A Towbin; Susan W Denfield
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

View more
  3 in total

1.  Mechanistic heterogeneity in contractile properties of α-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies.

Authors:  Tejas M Gupte; Farah Haque; Binnu Gangadharan; Margaret S Sunitha; Souhrid Mukherjee; Swetha Anandhan; Deepa Selvi Rani; Namita Mukundan; Amruta Jambekar; Kumarasamy Thangaraj; Ramanathan Sowdhamini; Ruth F Sommese; Suman Nag; James A Spudich; John A Mercer
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

Review 2.  Genetic testing in the contemporary diagnosis of cardiomyopathy.

Authors:  Amy Curry Sturm
Journal:  Curr Heart Fail Rep       Date:  2013-03

3.  Structural and protein interaction effects of hypertrophic and dilated cardiomyopathic mutations in alpha-tropomyosin.

Authors:  Audrey N Chang; Norma J Greenfield; Abhishek Singh; James D Potter; Jose R Pinto
Journal:  Front Physiol       Date:  2014-12-02       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.